Building A Fully Integrated Biotech Company: What It Takes
Executive Summary
A typical mature biotech company evolves over four discrete stages – from the initial discovery stage through the preclinical and early clinical stage, then to the late clinical trials and commercial build-out – before it becomes a fully integrated biotech company. The final transition is a make-or-break scenario for any biotech company, and high-quality marketed products alone don’t guarantee a successful transformation.
You may also be interested in...
Finding The Value In Shifting R&D Models
Consultancy McKinsey & Co. is optimistic about the future of R&D within the pharma industry, but says certain aspects of the organizations need to shift – making the companies leaner and more productive – to maintain the industry’s leadership position.
Can Isis Remain A Platform Company?
With a bulging pipeline, piles of cash, and Big Pharma partners knocking on its doors, Isis believes it is under no pressure to sell its own products. But several factors – including outside pressures and issues intrinsic to Isis’ platform model – are coming into play that may hasten its evolution into an integrated biopharma. And for the first time, Isis management appears open to the possibility.
Theravance Re-Introduces Vibativ In The U.S. Independently (For Now)
The biotech is bringing is long-plagued antibiotic back to U.S. patients, but is still searching for another company to help with commercialization efforts. Meanwhile, plans for its split and the launch of its partnered COPD drug are on track.